Dysentery

Dysentery is defined clinically as an acute inflammatory disorder of the gastrointestinal tract characterized by frequent, small-volume stools containing visible blood, mucus, and inflammatory exudates, accompanied by severe abdominal cramps, fever, and tenesmus (a painful, straining sensation of urgent, incomplete rectal evacuation).

Bacillary dysentery (Shigellosis) is an acute, highly infectious bacterial enteritis characterized by invasion, necrosis, and inflammatory destruction of the colonic and terminal ileal epithelium, leading to severe abdominal cramps, high fever, tenesmus, and frequent loose stools laden with blood and mucus.

Shigellosis is caused by bacteria of the genus Shigella, which belong to the family Enterobacteriaceae. They are Gram-negative, facultatively anaerobic, non-motile, non-spore-forming, non-lactose-fermenting bacilli, classified serologically into four distinct species:

• Shigella dysenteriae (Serogroup A): The most virulent species. Produces the potent Shiga toxin (Stx). Responsible for devastating, epidemic outbreaks of severe dysentery, life-threatening complications, and high mortality.
• Shigella flexneri (Serogroup B): The most common cause of endemic bacillary dysentery in low- and middle-income countries, including Uganda and sub-Saharan Africa. Associated with chronic, persistent infection and secondary nutritional stunting in children.
• Shigella boydii (Serogroup C): Less common globally, predominantly restricted to the Indian subcontinent.
• Shigella sonnei (Serogroup D): The predominant species in high-income and industrialized countries. Produces a milder illness, often presenting as watery diarrhea with low rates of frank mucosal ulceration.

• Exceptionally Low Infectious Inoculum: Unlike Vibrio cholerae or Salmonella which require the ingestion of hundreds of thousands to millions of organisms, ingestion of as few as 10 to 100 Shigella bacilli is sufficient to cause clinical disease. This high infectivity is due to the organism's extreme resistance to normal gastric acidity.
• Transmission Pathways: Primarily transmitted via the fecal-oral route:
  • Direct Person-to-Person Contact: Fecal contamination on hands, clothing, bedding, and toys, driving rapid household and institutional transmission (daycare centers, schools, refugee settlements, barracks, and prisons).
  • Indirect Ingestion: Consuming fecally contaminated water supplies, unpasteurized milk, raw vegetables, or street foods washed in untreated water.
  • Mechanical Vectors: Common houseflies (Musca domestica) feed on human feces in open pit latrines and mechanically deposit bacilli directly onto exposed food.

• Children aged 6 months to 5 years (due to lack of acquired mucosal immunity, frequent hand-to-mouth behaviors, and weaning from protective maternal IgA).
• Severely malnourished children (kwashiorkor and marasmus dramatically amplify case-fatality rates).
• Individuals living with advanced HIV disease (prone to severe bacteremia and protracted mucosal destruction).
• Displaced persons residing in overcrowded refugee camps, informal urban settlements, or flood-prone regions with collapsed water and sanitation infrastructure.

The pathogenesis of Shigella involves a multi-step cascade of cellular invasion, intracellular movement, macrophage apoptosis, and intense inflammatory tissue destruction:

1. Gastric Passage & Entry: Ingested bacilli survive the gastric acid barrier and transit through the small intestine into the distal colon and rectum. Because they lack flagella and cannot penetrate the thick apical brush border of mature enterocytes directly, they exploit specialized Microfold (M) cells located in the follicle-associated epithelium overlying lymphoid follicles (Peyer's patches).
2. Macrophage Transcytosis & Apoptosis: M cells endocytose the bacilli and deliver them to underlying sub-epithelial macrophages. Shigella uses a Type III Secretion System (T3SS) to inject invasion plasmid antigens (IpaB, IpaC, IpaD) into the macrophage cytoplasm, lysing the phagosome. Inside the macrophage, the bacterium activates caspase-1, inducing rapid macrophage pyroptosis (pro-inflammatory programmed cell death) and releasing high concentrations of IL-1β and IL-18.
3. Basolateral Invasion of Enterocytes: The released bacteria invade the basolateral surface of adjacent colonic enterocytes via T3SS-induced membrane ruffling and macropinocytosis. Once intracellular, the bacterium escapes into the host cell cytoplasm.
4. Actin Polymerization & Intercellular Spread (IcsA / VirG): Shigella utilizes an outer membrane protein called IcsA (VirG), which recruits the host cell's neural Wiskott-Aldrich syndrome protein (N-WASP) and the Arp2/3 complex to polymerize host actin monomers into an explosive "actin tail" at one bacterial pole. This actin comet tail propels the bacterium through the cytoplasm and pushes against the host cell membrane, forming finger-like protrusions that are engulfed by adjacent enterocytes. This allows the bacterium to spread laterally from cell to cell without entering the extracellular space, effectively evading circulating humoral antibodies and complement.
5. Mucosal Necrosis & Intense Infiltration: Intracellular bacterial replication and the release of inflammatory cytokines (IL-8) recruit massive numbers of polymorphonuclear neutrophils (PMNs) from the submucosal capillaries. Neutrophils migrate through tight junctions into the epithelial layer, destroying the intestinal barrier. The infected mucosa undergoes patchy ischemic necrosis, forming micro-abscesses, shedding dead epithelial cells, and creating superficial, bleeding ulcerations. The combination of extravasated blood, inflammatory leukocytes, necrotic debris, and mucus forms the characteristic dysenteric stool.
6. Shiga Toxin (Stx) Cytotoxicity: Produced predominantly by S. dysenteriae type 1. Stx is an AB5-subunit holotoxin. The B-subunits bind to the globotriaosylceramide (Gb3) glycolipid receptor on host endothelial cells; the catalytic A-subunit is endocytosed and cleaves an adenine residue from the 28S ribosomal RNA of the 60S ribosomal subunit, completely arresting eukaryotic protein synthesis and causing endothelial cell death. Absorbed Stx enters the systemic bloodstream, damaging renal glomerular microvasculature and triggering Hemolytic Uremic Syndrome (HUS).

Shigellosis characteristically evolves through two distinct phases:

• Initial Early Phase (Small Bowel Secretory Diarrhea): Begins abruptly within 12 to 48 hours of ingestion. Manifests with high-grade fever (>38.5°C to 40°C), constitutional symptoms (severe frontal headache, anorexia, lethargy, generalized myalgia), nausea, vomiting, and voluminous, watery diarrhea without blood. This initial watery phase is mediated by enterotoxins (ShET-1 and ShET-2) stimulating intestinal fluid secretion in the jejunum.
• Second Dysenteric Phase (Colonic Invasion): Occurs 24 to 72 hours later as bacteria invade the colon. The watery diarrhea subsides and is replaced by frequent (20 to 40 times daily), small-volume stools composed entirely of blood, thick mucus, and pus. Characterized by severe lower quadrant colicky abdominal pain and continuous, painful tenesmus. Young children may display continuous straining, rectal prolapse, and painful abdominal distension.

• Dehydration: Manifests as sunken eyes, dry buccal mucosa, loss of skin turgor, tachycardia, hypotension, and oliguria.
• Neurological Manifestations (Ekiri Syndrome): Febrile convulsions, encephalopathy, confusion, lethargy, meningismus, and obtundation, occurring frequently in young children with S. flexneri or S. dysenteriae infection, even prior to the onset of frank dysentery.
• Hypoglycemia & Severe Hyponatremia: Caused by metabolic exhaustion, impaired gluconeogenesis, and inappropriate antidiuretic hormone secretion (SIADH).

1. Stool Microscopy (Immediate Wet Mount):
   • Direct microscopic examination of fresh, warm, unstained stool or saline/methylene blue preparations.
   • Hallmark: Presence of dense sheets of polymorphonuclear leukocytes (>50 pus cells per high-power field), abundant erythrocytes, and cellular debris. The background is noticeably clear of motile protozoa.
2. Stool Culture & Sensitivity (The Gold Standard):
   • Collect fresh stool containing blood and mucus, or a rectal swab, and plate immediately onto selective media (MacConkey Agar, Xylose Lysine Deoxycholate [XLD] Agar, or Salmonella-Shigella [SS] Agar).
   • Colony Morphology: Non-lactose-fermenting, smooth, colorless, translucent colonies on MacConkey agar; pink/red translucent colonies without black centers (H2S negative) on XLD agar.
   • Biochemical Confirmation: Oxidase-negative, non-motile, glucose-fermenting without gas production (except certain S. flexneri biotypes), urea-negative, indole-variable.
   • Antimicrobial Susceptibility Testing: Vital due to widespread plasmid-mediated multi-drug resistance (MDR) against older antimicrobials.
3. Complete Blood Count (CBC): Marked leukocytosis (15,000 to 30,000 WBCs/μL) with a pronounced left shift (abundant band forms) or a severe leukemoid reaction (WBC counts exceeding 50,000/μL in children with S. dysenteriae type 1).
4. Serum Electrolytes & Renal Function: Urea, creatinine, sodium, potassium, and chloride monitoring to detect prerenal azotemia, acute tubular necrosis, or hemolytic uremic syndrome.

• Antimicrobial Therapy is Mandatory: While mild disease can be self-limiting, antimicrobial treatment is indicated for all patients with bloody diarrhea to shorten illness duration, eradicate fecal excretion of bacilli, and halt transmission.
• Absolute Contraindication of Antimotility Agents: Loperamide, Diphenoxylate-atropine, and opiates are strictly contraindicated. Suppressing intestinal peristalsis impedes the clearance of invasive bacteria and toxic luminal contents, significantly increasing the risk of toxic megacolon, bowel perforation, septic shock, and death.

• Oral Rehydration Therapy (ORT): Use WHO low-osmolarity Oral Rehydration Salts (ORS) solution to replace lost water and electrolytes. Encourage frequent, small sips.
• Intravenous Resuscitation: For patients with severe dehydration, hypovolemic shock, or intractable vomiting, rapidly infuse Ringer’s Lactate or Normal Saline (100 mL/kg divided per WHO Plan C guidelines).
• Zinc Supplementation: Reduces the duration, severity, and recurrence of diarrhea in children:
  • Infants <6 months: 10 mg elemental zinc orally once daily for 14 days.
  • Children ≥6 months to 5 years: 20 mg elemental zinc orally once daily for 14 days.
• Nutritional Management: Continue feeding without interruption. Do not withhold food. Provide frequent, small meals rich in potassium, digestible proteins, and energy (porridges, mashed bananas, boiled rice, soups, lean meats). For breastfed infants, maintain frequent on-demand breastfeeding. The historical "starve the bowel" or rigid "BRAT diet only" concept has been superseded by continuous, active, calorie-dense feeding to prevent acute nutritional deterioration.
• Antiemetics: If persistent vomiting prevents oral rehydration, administer Ondansetron (0.15 mg/kg oral/IV). Avoid high-dose Metoclopramide in young children due to acute extrapyramidal dystonic reactions.

• Hemolytic Uremic Syndrome (HUS): The classic triad of Microangiopathic Hemolytic Anemia, Thrombocytopenia, and Acute Renal Failure. Typically appears 7 to 10 days after dysentery onset due to systemic absorption of Shiga toxin. Microvascular endothelial injury in renal glomeruli triggers platelet microthrombi, consuming platelets, shearing erythrocytes (producing fragmented schistocytes on peripheral blood smear), and causing severe oliguric renal failure.
• Toxic Megacolon: Severe transmural inflammation and bacterial invasion paralyze the colonic muscularis propria, causing acute, massive non-obstructive dilatation of the transverse colon (>6 cm diameter on abdominal radiograph). Marked by high fever, prostration, absent bowel sounds, severe rebound tenderness, and high risk of bowel perforation and peritonitis.
• Intestinal Perforation & Peritonitis: Deep mucosal ulcerations eroding through the muscularis and serosa of the colon, spilling fecal matter into the peritoneal cavity.
• Rectal Prolapse: Full-thickness or mucosal evagination of the rectum through the anal sphincter, provoked by relentless tenesmus, straining, and pelvic muscle fatigue in young, malnourished children.
• Post-Infectious Reactive Arthritis (Reiter’s Syndrome): Triad of arthritis, urethritis, and conjunctivitis occurring 1 to 4 weeks after infection with Shigella flexneri, occurring predominantly in HLA-B27 positive individuals.
• Severe Metabolic Disturbances: Hyponatremia (SIADH), severe hypokalemia, and refractory hypoglycemia.

Amoebiasis is an invasive parasitic infection caused by the pseudopod-forming protozoan Entamoeba histolytica, presenting either as intestinal disease (ranging from asymptomatic colonization to acute amoebic dysentery, fulminant necrotizing colitis, and amoeboma) or extra-intestinal disease, most notably Amoebic Liver Abscess (ALA).

Entamoeba histolytica exists in two distinct biological forms during its life cycle:

• The Cyst Stage (Infective & Resistant Form):
  • Spherical, non-motile, measuring 10 to 15 μm in diameter.
  • Enclosed by a rigid, refractile, chitinous wall that provides protection against environmental desiccation, osmotic lysis, and normal municipal water chlorination concentrations. Can survive for weeks in moist soil or cold water.
  • Morphology: Contains 1 to 4 characteristic round nuclei with a tiny, centrally located karyosome (endosome) and fine, evenly distributed peripheral chromatin, accompanied by blunt-ended, sausage-shaped chromatoid bodies in immature cysts.
  • Function: The mature quadrinucleate cyst is the sole infective stage transmitted via fecal contamination. Cysts do not cause tissue invasion or disease symptoms.
• The Trophozoite Stage (Invasive, Amoeboid & Pathogenic Form):
  • Pleomorphic, actively motile organism measuring 20 to 40 μm in diameter.
  • Moves directionally using rapidly projecting, finger-like, clear ectoplasmic pseudopodia.
  • Morphology: Contains a single nucleus with a delicate central karyosome. The endoplasm is finely granular and, during invasive disease, contains ingested host red blood cells (erythrophagocytosis).
  • Function: The vegetative, tissue-destroying form that colonizes the colon, invades tissue, and causes clinical ulceration. Trophozoites are labile; they die rapidly in the external environment and are destroyed by gastric acid if ingested, meaning they cannot transmit the infection.

• Primary Transmission: Ingestion of mature quadrinucleate cysts from fecally contaminated drinking water, uncooked vegetables fertilized with human nightsoil, unwashed hands of food handlers, or unpeeled fruits.
• Direct Sexual Transmission: Oral-anal sexual contact (fecal-oral contact), common among men who have sex with men (MSM).
• High-Risk Populations:
  • Travelers or immigrants returning from highly endemic tropical countries.
  • Institutionalized individuals with intellectual disabilities.
  • Immunocompromised patients, corticosteroid users, pregnant women, and malnourished individuals (who face dramatically increased risk of fulminant necrotizing colitis and fatal liver abscess rupture).

1. Excystation: Ingested quadrinucleate cysts pass through the stomach unharmed. In the alkaline environment of the terminal ileum, excystation occurs: the cyst wall dissolves, releasing a tetranucleate metacyst that divides into 8 motile amoebic trophozoites that colonize the cecum and ascending colon.
2. Adherence (Gal/GalNAc Lectin): Trophozoites attach to colonic mucins and the apical membrane of enterocytes via a surface transmembrane heterodimer: the Galactose/N-acetylgalactosamine (Gal/GalNAc)-specific lectin.
3. Contact-Dependent Lysis & Amoebapores: Upon binding, trophozoites insert small, amphipathic peptide channels termed amoebapores into the host cell membrane, creating ion-permeable pores that cause rapid cell lysis. They concurrently release potent cysteine proteinases (CPs) that degrade the mucosal protective mucus layer, cleave host extracellular matrix proteins (collagen, fibronectin), and inactivate host secretory IgA and complement components (C3a, C5a).
4. Flask-Shaped Ulcer Development: Trophozoites breach the single-cell epithelial layer and enter the lamina propria. The muscularis mucosae forms a temporary barrier. Unable to penetrate downward easily, the parasites spread laterally within the loose submucosal connective tissue, digesting tissue planes. This creates the classic flask-shaped (collar-button) ulcer: a narrow, pinhead-sized mucosal neck opening into a widely excavated, necrotic base situated within the submucosa. Intervening mucosal regions between ulcers remain entirely normal and uninflamed.

1. Hematogenous Seeding: As submucosal ulcers erode deeper, trophozoites erode through the walls of the tributary venules of the superior mesenteric vein. Entering the mesenteric venous circulation, they travel via the portal vein directly into the liver parenchyma.
2. Hepatic Sinusoid Colonization: The amoebae lodge in hepatic sinusoids, most commonly within the posterosuperior aspect of the right hepatic lobe (80% of cases), reflecting the preferential laminar stream of blood from the superior mesenteric vein into the right portal branch.
3. Liquefactive Necrosis ("Anchovy Paste"): Trophozoites release cysteine proteinases that destroy surrounding hepatocytes and degrade cellular architecture. Recruited host neutrophils are lysed by the amoebae, spilling toxic lysosomal enzymes that worsen tissue destruction. This results in progressive, aseptic liquefactive necrosis of hepatic parenchyma.
4. Abscess Morphology: The center of the abscess contains thick, odorless, reddish-brown, sterile, liquefied necrotic debris classically described as "anchovy paste" or "chocolate pudding" fluid. This fluid consists of dead hepatocytes, fragmented cellular debris, and altered blood, and is completely free of bacterial infection and leukocytes. Live, invading trophozoites are NOT found floating in the necrotic pus center, but reside exclusively at the viable, advancing periphery within the fibrous wall of the abscess.

• Asymptomatic Cyst Passage: Seen in >90% of individuals infected with E. histolytica; they shed infective cysts in stool for months without developing tissue invasion or clinical symptoms.
• Acute / Subacute Amoebic Dysentery:
  • Gradual onset over 1 to 3 weeks of worsening diarrhea, lower abdominal colicky pain, flatulence, and fatigue.
  • Stools progress from semi-formed feces to 4 to 10 loose, voluminous bowel movements daily, containing dark altered blood and copious mucus thoroughly blended with fecal matter, imparting an offensive, foul odor.
  • Tenesmus is mild to moderate (severe only when ulcers involve the rectosigmoid junction).
  • High fever is uncommon (present in <40% of uncomplicated colitis cases, distinguishing it from the high-spiking pyrexia of shigellosis).
• Fulminant / Necrotizing Amoebic Colitis: Rare (<0.5%), catastrophic complication occurring primarily in pregnant women, malnourished children, or patients inadvertently treated with corticosteroids. Manifests with high fever, severe continuous abdominal pain, profuse bloody diarrhea, rebound tenderness, toxic megacolon, diffuse intestinal gangrene, and high mortality (>40%).
• Amoeboma: A chronic, inflammatory, granulomatous mass lesion formed in response to persistent amoebic ulceration, occurring most commonly in the cecum or ascending colon. Simulates an obstructing adenocarcinoma on colonoscopy and CT imaging.

The most common extra-intestinal manifestation, occurring in approximately 1% to 4% of symptomatic patients. Males are affected 7 to 10 times more frequently than females (especially aged 20–50 years), hypothesized to be due to testosterone-driven immune differences or hepatic iron storage differences.

• The Classical Diagnostic Triad:
  1. High, Spiking Fever: Intermittent or remittent pyrexia (38.5°C to 40°C), accompanied by prominent nocturnal rigors and profuse diaphoresis.
  2. Right Upper Quadrant (RUQ) Abdominal Pain: Constant, dull, aching, or throbbing pain localized over the hepatic area, often radiating superiorly to the right shoulder or right scapular region (phrenic nerve irritation). Pain is aggravated by coughing, deep inspiration, or turning onto the right side.
  3. Tender Hepatomegaly: Palpable, smoothly enlarged liver with exquisite point tenderness elicited by light percussion over the lower right intercostal spaces (between the 7th and 10th ribs).
• Systemic Signs: Significant anorexia, rapid weight loss, physical exhaustion, mild jaundice (present in <10% unless multiple/large abscesses obstruct the biliary tree), right-sided pleural effusion, and basilar lung atelectasis.
• Clinical Pearl: More than 70% of patients with amoebic liver abscess have NO concurrent active diarrhea or intestinal dysentery at the time of presentation; their primary intestinal infection occurred months or years prior.

1. Stool Microscopy:
   • Examine fresh, warm stool (within 30 minutes of passage) in saline and Lugol's iodine preparations.
   • Finding in Dysentery: Identification of actively motile E. histolytica trophozoites with clear, finger-like pseudopodia containing ingested red blood cells (erythrophagocytosis). Ingested RBCs definitively establish invasive pathogenic E. histolytica, excluding E. dispar.
   • Finding in Chronic/Asymptomatic States: Spherical cysts with 1 to 4 nuclei and blunt chromatoid bars.
   • Cellular Background: Few pus cells (leukocytes are lysed by amoebic enzymes), clumped RBCs, and Charcot-Leyden crystals (diamond-shaped eosinophil breakdown products).
2. Stool Antigen Detection & Molecular Assays (ELISA & PCR):
   • Fecal Antigen ELISA: Commercial monoclonal antibody assays detecting the Gal/GalNAc lectin of E. histolytica in fresh stool. Sensitivity >95%; highly specific, differentiating E. histolytica from E. dispar.
   • Polymerase Chain Reaction (PCR): Amplifies 16S-like rRNA genes; considered the international diagnostic reference standard.
3. Serological Antibody Testing (Essential for Amoebic Liver Abscess):
   • Indirect Hemagglutination (IHA) or Enzyme Immunoassay (EIA) for circulating anti-amoebic antibodies.
   • Positive in >95% of patients with Amoebic Liver Abscess and >85% of patients with invasive colitis. Serology remains positive for years after cure; a negative serology virtually excludes the diagnosis of amoebic liver abscess.
4. Abdominal Ultrasonography (The First-Line Imaging Modality for ALA):
   • Demonstrates a round or oval, well-defined, hypoechoic, non-calcified cystic cavity with low-level internal echoes and continuous internal acoustic enhancement, located in 80% of cases in the right hepatic lobe subcapsular zone.
5. Diagnostic / Therapeutic Needle Aspiration:
   • Indicated for large abscesses at risk of imminent rupture, abscesses in the left hepatic lobe (risk of pericardial rupture), or to rule out a pyogenic bacterial abscess.
   • Fluid Characteristics: Thick, reddish-brown, odorless "anchovy-paste" material. Microscopic examination of aspirate reveals amorphous proteinaceous necrotic debris without polymorphonuclear pus cells. Trophozoites are rarely identified in the fluid itself (they reside in the abscess wall). Gram stain and bacterial cultures are sterile.

CRITICAL CLINICAL MANDATE: Medical cure of invasive amoebiasis REQUIRES sequential therapy using two distinct classes of amoebicides:

1. Step 1: A Systemic Tissue Amoebicide (Metronidazole or Tinidazole) to eradicate invasive trophozoites residing within the intestinal mucosa and liver parenchyma.
2. Step 2: A Luminal Amoebicide (Diloxanide furoate, Paromomycin, or Iodoquinol) to eradicate residual cysts and trophozoites residing in the colonic lumen. Tissue amoebicides achieve sub-therapeutic concentrations in the bowel lumen; failure to administer a subsequent luminal amoebicide results in a relapse rate of up to 40% to 50% and continued transmission of infective cysts.

• Medical Cure: Over 95% of uncomplicated amoebic liver abscesses respond to medical management alone with Metronidazole (750 mg 8-hourly for 10 days) or Tinidazole (2 g daily for 5 days), accompanied by marked clinical improvement (fever lysis and pain resolution) within 72 to 96 hours.
• Indications for Percutaneous Ultrasound-Guided Needle Aspiration:
  • High risk of imminent rupture: abscess diameter > 5 cm or thin liver tissue mantle (<10 mm) over the abscess.
  • Left hepatic lobe abscess (high risk of fatal intrapericardial rupture causing cardiac tamponade).
  • Complete lack of clinical defervescence or worsening pain after 72 hours of systemic metronidazole therapy.
  • Diagnostic uncertainty: inability to rule out a bacterial pyogenic liver abscess.

• Rupture of Amoebic Liver Abscess: The most catastrophic complication:
  • Intraperitoneal Rupture: Spillage of necrotic amoebic debris into the peritoneal cavity, precipitating acute generalized peritonitis, shock, and high mortality.
  • Intrathoracic Rupture: Erosion through the diaphragm into the right pleural space (amoebic empyema) or bronchial tree, causing patients to cough up large volumes of characteristic "anchovy-paste" sputum (hepatobronchial fistula).
  • Intrapericardial Rupture: Left lobe abscesses eroding directly through the left diaphragm into the pericardial sac, triggering acute cardiac tamponade, pulsus paradoxus, hemodynamic collapse, and immediate death if not decompressed.
• Fulminant Necrotizing Colitis with Toxic Megacolon: Massive transmural colonic gangrene, multiple perforations, and peritonitis.
• Amoeboma (Amoebic Granuloma): A large, firm, vascular, fibrous inflammatory pseudotumor of the bowel wall that can cause complete mechanical large bowel obstruction or intussusception.
• Secondary Bacterial Infection of Abscess: Superinfection of the sterile liver abscess with enteric bacteria (E. coli, Klebsiella), transforming it into a mixed pyogenic abscess requiring broad-spectrum intravenous antibiotics.

1. Safe Water Treatment:
   • Boiling Water: The most reliable method for destroying both Shigella bacteria and Entamoeba cysts. Water must be brought to a rolling boil for a full 1 to 3 minutes.
   • The Chlorination Limitation: Standard municipal water chlorination concentrations easily destroy vegetative Shigella bacteria, but normal chlorine levels do NOT kill thick-walled Entamoeba histolytica cysts. Water purification in amoebic endemic areas requires filtration (pore size ≤ 1 micron) followed by boiling or specialized ultraviolet (UV) treatment.
2. Sanitary Excreta Disposal: Construction and consistent utilization of ventilated improved pit (VIP) latrines and pour-flush toilets. Complete cessation of open defecation, especially around agricultural fields, rivers, and water collection points. Prohibit the use of untreated human nightsoil as agricultural fertilizer.
3. Strict Hand Hygiene: Mandatory handwashing with clean running water and soap at critical times: before preparing food, before eating or feeding children, after using the toilet, and after cleaning a child's perineum.
4. Safe Food Handling & Food Handler Screening:
   • Food must be thoroughly cooked to an internal temperature >70°C and eaten hot.
   • Raw vegetables and salad greens grown in contaminated soil must be thoroughly washed in clean, boiled water or peeled completely; unpeeled raw vegetables should be avoided in endemic zones.
   • Exclude all food handlers with active diarrhea or documented asymptomatic cyst passage until treatment completion and negative repeat stool examinations.
5. Vector Control: Control housefly populations using insecticide sprays, flyscreens on kitchen doors and windows, and covering all food items and latrine drop-holes.

• World Health Organization. Guidelines for the Control of Shigellosis, including Epidemics Due to Shigella dysenteriae 1. Geneva: WHO Press.
• World Health Organization. Amoebiasis: WHO/PAHO/UNESCO Technical Report. Bulletin of the World Health Organization.
• Ministry of Health Uganda. Uganda Clinical Guidelines (UCG) 2023: National Guidelines for Common Medical Conditions. Section: Gastrointestinal Tract Infections (Dysentery & Invasive Colitis). Kampala, Uganda.
• Doctors Revision Uganda. Clinical Guide: Bacillary Dysentery (Shigellosis) Pathology, Diagnosis and Management.
• Doctors Revision Uganda. Clinical Guide: Amoebiasis (Amoebic Colitis and Amoebic Liver Abscess) Protocol.
• Kotloff KL, et al. Shigellosis. The Lancet, 391(10122), 801-812.
• Haque R, et al. Amebiasis. New England Journal of Medicine, 348(16), 1565-1573.